HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1166417Generated: October 29, 2026
Triethylamine → 4-(3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)-propyl)-2-piperazinecarboxylic acid ethyl ester
https://huagongshe.com/reaction/1166417
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | Methanesulfonyl chloride | HCID 31297 | — |
| Reactant | Ethyl Piperazine-2-carboxylate | HCID 10633257 | — |
| Reactant | 3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)-1-propanol | HCID 11021414 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | 4-(3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)-propyl)-2-piperazinecarboxylic acid ethyl ester | HCID 54368737 | 33% |
Reaction Steps
To a stirred solution of 3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)-1-propanol (1.17 g, 0.0046 mol, prepared similarly as described in example 2) and triethylamine (1.18 g, 0.012 mol) in toluene (30 ml) at 0° C., methanesulfonyl chloride (0.70 ml, 0.009 mol) was added dropwise over 10 minutes. The resulting mixture was stirred at 0° C. for 1 h. Toluene (50 ml) and water (100 ml) were added, and the phases were separated. The aqueous layer was extracted with toluene (50 ml), and the combined organic phases were washed with brine (2×100 ml), dried (MgSO4) and concentrated in vacuo. The residue was dissolved in acetonitrile (10 ml) and the above 2-piperazine-carboxylic acid ethyl ester (1.40 g, 0.0089 mol), potassium carbonate (0.67 g, 0.0049 mol) and toluene (5 ml) were added. The resulting mixture was heated at reflux temperature for 18 h. Water (50 ml) was added, and the mixture was extracted with ethyl acetate (3×20 ml). The combined organic extracts were washed with brine (2×20 ml), dried (MgSO4) and concentrated in vacuo. The residue was purified by column chromatography on silica gel (27 g) using a gradient of methanol and ethyl acetate (5:100→20:100), affording 0.6 g (33%) of 4-(3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)-1-propyl)-2-piperazinecarboxylic acid ethyl ester as an oil.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06613791B1 |
|---|
| Source dataset | uspto-grants-2003_09 |
|---|
| ORD ID | ord-b2df8b35561947ae9b0e10498ae922ff |
|---|
| Source note | uspto-grants-2003_09 |
|---|